S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
Are Gene Therapy Stocks The Market's Next Big Winners?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Stocks to Benefit from the Aging Population
This May Have Ended Alibaba's Winter, But Is It Time To Buy?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
AI Boosts Duolingo As Company Posts First Profit
Alcoa, Krispy Kreme fall; Williams-Sonoma, Ford rise, Monday, 9/25/2023
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
Are Gene Therapy Stocks The Market's Next Big Winners?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Stocks to Benefit from the Aging Population
This May Have Ended Alibaba's Winter, But Is It Time To Buy?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
AI Boosts Duolingo As Company Posts First Profit
Alcoa, Krispy Kreme fall; Williams-Sonoma, Ford rise, Monday, 9/25/2023
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
Are Gene Therapy Stocks The Market's Next Big Winners?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Stocks to Benefit from the Aging Population
This May Have Ended Alibaba's Winter, But Is It Time To Buy?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
AI Boosts Duolingo As Company Posts First Profit
Alcoa, Krispy Kreme fall; Williams-Sonoma, Ford rise, Monday, 9/25/2023
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
Are Gene Therapy Stocks The Market's Next Big Winners?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Stocks to Benefit from the Aging Population
This May Have Ended Alibaba's Winter, But Is It Time To Buy?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
AI Boosts Duolingo As Company Posts First Profit
Alcoa, Krispy Kreme fall; Williams-Sonoma, Ford rise, Monday, 9/25/2023
NYSE:CPUH

Compute Health Acquisition (CPUH) Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$10.31
$10.77
50-Day Range
$10.20
$10.68
52-Week Range
$9.70
$10.94
Volume
41,500 shs
Average Volume
39,058 shs
Market Capitalization
$318.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CPUH vs. IPXX, KAII, CXAC, BTWN, RENE, SLVR, FIAC, NPAB, JGGC, and LCAA

Should you be buying Compute Health Acquisition stock or one of its competitors? The main competitors of Compute Health Acquisition include Inflection Point Acquisition Corp. II (IPXX), Kismet Acquisition Two (KAII), C5 Acquisition (CXAC), Bridgetown (BTWN), Cartesian Growth Co. II (RENE), SILVERspac (SLVR), Focus Impact Acquisition (FIAC), New Providence Acquisition Corp. II (NPAB), Jaguar Global Growth Co. I (JGGC), and L Catterton Asia Acquisition (LCAA). These companies are all part of the "holding & other investment offices" industry.

Compute Health Acquisition vs.

Compute Health Acquisition (NYSE:CPUH) and Inflection Point Acquisition Corp. II (NASDAQ:IPXX) are both small-cap unclassified companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations, valuation and community ranking.

Compute Health Acquisition and Inflection Point Acquisition Corp. II both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Compute Health AcquisitionN/AN/A
Inflection Point Acquisition Corp. IIN/AN/A

15.3% of Compute Health Acquisition shares are held by institutional investors. 20.0% of Compute Health Acquisition shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Inflection Point Acquisition Corp. II's return on equity of 0.00% beat Compute Health Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Compute Health AcquisitionN/A -23.80% 1.31%
Inflection Point Acquisition Corp. II N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Compute Health Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Inflection Point Acquisition Corp. II
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Compute Health Acquisition's average media sentiment score of 0.00 equaled Inflection Point Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
Compute Health Acquisition Neutral
Inflection Point Acquisition Corp. II Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Compute Health AcquisitionN/AN/A$32.37MN/AN/A
Inflection Point Acquisition Corp. IIN/AN/AN/AN/AN/A

Summary

Compute Health Acquisition beats Inflection Point Acquisition Corp. II on 3 of the 4 factors compared between the two stocks.


Get Compute Health Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for CPUH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CPUH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CPUH vs. The Competition

MetricCompute Health AcquisitionHolding Offices IndustryUnclassified SectorNYSE Exchange
Market Cap$318.67M$255.86M$162.08M$15.27B
Dividend YieldN/A8.23%N/A3.69%
P/E RatioN/A3.032.6619.04
Price / SalesN/A28.440.488.18
Price / Cash6.9058.4860.2815.14
Price / Book-27.2690.53355.356.75
Net Income$32.37M$10.82M$8.50M$899.71M

Compute Health Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IPXX
Inflection Point Acquisition Corp. II
0 of 5 stars
$10.20
-0.1%
N/AN/A$318.75MN/A0.00N/APositive News
KAII
Kismet Acquisition Two
0 of 5 stars
$10.70
flat
N/AN/A$312.98MN/A0.00N/A
CXAC
C5 Acquisition
0 of 5 stars
$10.88
+0.1%
N/A+8.3%$312.80MN/A0.00N/ANegative News
BTWN
Bridgetown
0 of 5 stars
$10.37
+0.2%
N/A+3.6%$310.79MN/A-115.211
RENE
Cartesian Growth Co. II
0 of 5 stars
$10.78
+0.1%
N/A+10.5%$309.93MN/A0.00N/APositive News
SLVR
SILVERspac
0 of 5 stars
$10.48
+0.2%
N/A+7.7%$327.59MN/A0.002,021Negative News
FIAC
Focus Impact Acquisition
0 of 5 stars
$10.77
+0.2%
N/A+7.8%$309.64MN/A0.002Negative News
NPAB
New Providence Acquisition Corp. II
0 of 5 stars
$10.50
flat
N/A+7.4%$327.97MN/A0.002,021Positive News
JGGC
Jaguar Global Growth Co. I
0 of 5 stars
$10.71
+0.1%
N/A-7.4%$328.48MN/A0.00N/APositive News
LCAA
L Catterton Asia Acquisition
0 of 5 stars
$10.64
+0.2%
N/A+7.7%$308.03MN/A532.273

Related Companies and Tools

This page (NYSE:CPUH) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -